Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.
about
Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA contentThe Vpr protein from HIV-1: distinct roles along the viral life cycleHuman immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycleHuman immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzymeRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesHIV Associated Neurocognitive DisordersLentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cellsExtracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathologyRegulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.HIV-1 induces DCIR expression in CD4+ T cells.Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr SequencesHuman immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expressionGenetic variation and HIV-associated neurologic disease.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisHIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latencyHIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionHIV-1 transcriptional regulation in the central nervous system and implications for HIV cure researchThe HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particlesA conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.Inducible human immunodeficiency virus type 1 packaging cell linesVpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes.Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.HIV-1, reactive oxygen species, and vascular complicationsExtracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir.Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophagesHIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.HIV accessory proteins: emerging therapeutic targets.Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentHuman immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways.
P2860
Q21245103-BFA4654D-F3EB-4413-B523-5864044EAE12Q21245211-A7CE36CA-F13A-4A1C-935D-7ADF3D6E50FEQ24523263-CEA36344-5206-48D1-97AF-0516753793DCQ24629787-6820DE47-14DD-4433-BA80-E5E490E6525AQ24682903-A4122350-9412-49DD-8FD2-A44EC087DFF4Q24684302-66189DB7-1D7B-47C3-8105-0009719CEEE5Q26829535-485B6534-73BE-497C-A4F8-FCBBB11AED73Q27023968-A2131AA5-1AF7-47CF-879C-CBAA5AA36D11Q30789734-8626D823-758C-4AB9-8375-867CD6890660Q32068509-ADD5715A-B6AB-4F29-A9A5-40C641A0F152Q33587139-F3944273-ADC2-463D-BEFB-6CB015047069Q33644889-4AAC500F-012D-4510-AA87-E522E20C069BQ33745009-C0EB3376-4625-429F-B12B-64A4A99962ADQ33750035-631D0F30-5F6D-4141-A3C9-4EDF25001AC9Q33768060-BCC70E13-C7D7-4881-B30C-B97A8A75B667Q33784862-8D502079-E1AC-4DBB-B912-84DB4ADBC650Q33804558-B1727D78-33C4-446A-9769-07A476908F48Q33819189-446429C3-8EEC-4F7E-B29D-9DE23592D611Q34010283-3C23980C-5762-47C8-A714-C80F707F33A7Q34098372-CCAED4E6-546E-4BCD-9026-0BBD1CFD4218Q34362915-0571688C-94D7-4FD8-8DDE-1634D672A499Q34957142-147409F7-469D-4F3F-8F87-90FAFC84E1E8Q35009720-627098F3-C2ED-474D-8724-7808B2C607E1Q35834594-3CE21A47-08C0-42A9-9423-08272F11FA39Q35850368-D13BB57F-1DFB-46CE-9E04-7652BBD900DFQ35853370-FB2C865A-0CD4-45A4-B5E7-151B76494CE6Q35864277-8BB08438-15E1-4A90-8F50-DDACD4B098EAQ35888756-4367C007-79E1-491A-9DA5-94BC0B93B04DQ35890940-810E4FB4-F88C-44D2-96F0-49098A4F0BFBQ35943050-AEF76AED-606F-4381-98AE-0C74725F2396Q36040759-551031ED-D4F0-4B90-BF07-6316210D2EB1Q36098705-2DA0C81F-AC19-4AEE-88CF-CD654AA62013Q36400526-688BCDE4-7470-49A7-9747-72A7DABAA338Q36428308-A81C1A58-0B01-46D0-B024-6F68564496E2Q36437528-98028D15-E443-4B4B-AD40-91E0D4CAB55BQ36706005-F67ACBF8-1197-4E1B-8463-61B09EFD1138Q37007632-736BC564-040E-4A93-8ADA-F3AF574EF718Q37063467-837505C8-6758-4C7B-809B-A496BDBE3180Q37127522-B0AC30B7-A29C-4644-B3CC-4110039010D1Q37319262-7E48461D-BCEC-4DDB-BFD8-E54CE042ACA5
P2860
Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Extracellular Vpr protein incr ...... eactivates virus from latency.
@ast
Extracellular Vpr protein incr ...... eactivates virus from latency.
@en
type
label
Extracellular Vpr protein incr ...... eactivates virus from latency.
@ast
Extracellular Vpr protein incr ...... eactivates virus from latency.
@en
prefLabel
Extracellular Vpr protein incr ...... eactivates virus from latency.
@ast
Extracellular Vpr protein incr ...... eactivates virus from latency.
@en
P2093
P2860
P1433
P1476
Extracellular Vpr protein incr ...... reactivates virus from latency
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z